If this SPL consists of inactivated NDCs listed via the FDA initiated compliance action, They are going to be specified as a result.Phenobarbital is contraindicated in patients who will be hypersensitive to barbiturates, in clients with a background of manifest or latent porphyria, As well as in sufferers with marked impairment of liver function or